Theravance Biopharma Inc Net Asset Momentum
Theravance Biopharma Inc net asset momentum. Theravance Biopharma Inc (0TB) recorded a net asset momentum of -17.6% as of December 2024, with net assets of €175.54 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore how much does Theravance Biopharma Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Theravance Biopharma Inc (2014–2024)
Net asset momentum of Theravance Biopharma Inc from 2014 to 2024. This chart tracks Theravance Biopharma Inc's year-over-year net asset growth across 11 annual reporting periods from 2014 to 2024. The most recent momentum reading is -17.6%, with net assets of €175.54 Million EUR as of December 2024. See 0TB net assets for net asset value and shareholders' equity analysis.
Theravance Biopharma Inc Net Asset Momentum by Year (2014–2024)
Theravance Biopharma Inc net asset momentum by year from 2014 to 2024. The table below shows the complete annual net asset history for Theravance Biopharma Inc from 2014 to 2024, covering 11 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Theravance Biopharma Inc market capitalisation.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | €175.54 Million | €354.16 Million | €178.62 Million | ▼ -17.6% |
| 2023 | €213.00 Million | €382.00 Million | €169.00 Million | ▼ -51.8% |
| 2022 | €441.80 Million | €607.40 Million | €165.60 Million | ▲ +230.5% |
| 2021 | €-338.57 Million | €374.82 Million | €713.39 Million | ▼ -11.5% |
| 2020 | €-303.75 Million | €469.06 Million | €772.81 Million | ▼ -35.7% |
| 2019 | €-223.84 Million | €408.83 Million | €632.67 Million | ▼ -333.9% |
| 2018 | €-51.59 Million | €560.24 Million | €611.82 Million | ▼ -144.8% |
| 2017 | €115.18 Million | €441.40 Million | €326.22 Million | ▼ -67.1% |
| 2016 | €350.23 Million | €639.25 Million | €289.02 Million | ▲ +44.1% |
| 2015 | €243.06 Million | €300.12 Million | €57.05 Million | ▼ -16.1% |
| 2014 | €289.79 Million | €337.77 Million | €47.98 Million | — |